🧪 A study from @MirandaKusters and colleagues sought to determine the prognostic value of lateral #lymphnode size and malignant features - such as internal heterogeneity, irregular margins, and more - in patients with advanced #rectalcancer: https://t.co/c8lmsxxsSl
A 50% reduction in radiotherapy use for non-locally advanced rectal cancer did not compromise cancer-related outcomes at a national level. Optimizing clinical staging and surgery has enabled safe de-intensification of treatment. https://t.co/48ykLwrGRF
@mirandakusters@sannehazen
A 50% reduction in radiotherapy use for non-locally advanced rectal cancer did not compromise cancer-related outcomes at a national level. Optimizing clinical staging and surgery has enabled safe de-intensification of treatment. https://t.co/D76jty05Mi @mirandakusters@sannehazen
On 21-11 Tania Sluckin obtained her doctoral degree by defending her thesis entitled "lateral lymph nodes in rectal cancer". This thesis stresses the importance of adequate treatment of lateral lymph nodes and the LaNoReC trial. Want to receive a PDF? Mail [email protected]
Lateral lymph nodes during the @ESSOnews 142 conference! On Thursday 26th of October the prognostic implications of the number of lateral lymph nodes and their malignant features were discussed.
Publication alert: node picking or partial LLND do not decrease lateral recurrence risk in rectal cancer patients with enlarged nodes. In the LaNoReC these patients undergo a complete LLND aiming to lower the risk to <6% https://t.co/kE3liWERl7 #SoMe4Surgery#rectalcancerresearch
The renewed Dutch delineation guideline has been approved by the Dutch GI radiotherapy association (LPRGE)! This guideline will guarantee uniform delineation and coverage of lateral lymph nodes in the LaNoReC study. Want to join the next online training? [email protected]
Update @LaNoReCstudy: the study has become a registration study, not subject to ethical restrictions, open for ALL patients with enlarged (≥7.0mm) or intermediate (5.0-6.9mm) lateral nodes with ANY neoadjuvant treatment, with a new protocol. Keen to join? [email protected]
The Special Issue dedicated to Advanced Pelvic Malignancies is out! Massive kudos to @HelenMohan1 who edited the SI and put together a stellar team of world-renowned experts dedicated to this challenging field
Full issue 👉 https://t.co/8tBSwo3bGh
@ESSOnews@EYSAC1@BASO_ACS
International rectal cancer forum is back!! Yes 2022!! Yes in person!! Mark your calendar now!! Hosted by the queen in coloproctology prof. Angelita Habr-Gama October 31st and November 1st. Don’t miss it!!